Neuralio OÜ

Active Registry code 16878621 OÜ Tallinn Registered 13 Dec 2023
Compare

Neuralio OÜ is a OÜ based in Tallinn, registry code 16878621, status: active. Main activity: Research and experimental development on natural sciences and engineering. According to EMTA, turnover for Q3 2026 was €11 182 with 1 employees.

Turnover
11 182 €
↑ 6 477.6% vs Q2 2026
State taxes
—
Labour taxes
—
Employees
1

Q3 2026 · data from the Tax and Customs Board (EMTA)

Position in the industry Scientific research and development · EMTAK 72

  • Turnover · Q3 2026 11 182 €
    industry median 14 442 € · companies in the industry: 318
  • Revenue · 2025 10 000 €
    industry median 0 € · companies in the industry: 1 073
  • Net profit margin · 2025 108.7 %
    industry median 13.5 % · companies in the industry: 597

Taxes and turnover

Q1 2025 – Q3 2026
Turnover, € Q3 2026: 11 182 € · +6 477.6% vs Q2 2026 · industry median 14 442 € · above 43% of the industry
05 00010 00015 00020 000Q1 2025 Company: 19 800 € Industry median: 15 203 €Q1·25Q2 2025 Company: 626 € Industry median: 14 420 €Q2·25Q3 2025 Company: 347 € Industry median: 13 763 €Q3·25Q4 2025 Company: 171 € Industry median: 13 976 €Q4·25Q1 2026 Company: 13 511 € Industry median: 14 268 €Q1·26Q2 2026 Company: 170 € Industry median: 14 545 €Q2·26Q3 2026 Company: 11 182 € Industry median: 14 442 €Q3·2605 00010 00015 00020 000Q1 2025 Company: 19 800 € Industry median: 15 203 €Q1·25Q2 2025 Company: 626 € Industry median: 14 420 €Q3 2025 Company: 347 € Industry median: 13 763 €Q3·25Q4 2025 Company: 171 € Industry median: 13 976 €Q1 2026 Company: 13 511 € Industry median: 14 268 €Q1·26Q2 2026 Company: 170 € Industry median: 14 545 €Q3 2026 Company: 11 182 € Industry median: 14 442 €Q3·26
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Employees Q3 2026: 1
0.00.20.40.60.81.0Q1 2025 Company: —Q1·25Q2 2025 Company: —Q2·25Q3 2025 Company: —Q3·25Q4 2025 Company: —Q4·25Q1 2026 Company: —Q1·26Q2 2026 Company: —Q2·26Q3 2026 Company: 1Q3·260.00.20.40.60.81.0Q1 2025 Company: —Q1·25Q2 2025 Company: —Q3 2025 Company: —Q3·25Q4 2025 Company: —Q1 2026 Company: —Q1·26Q2 2026 Company: —Q3 2026 Company: 1Q3·26
Figures by quarter
Quarter Turnover, € State taxes, € Labour taxes, € Employees
Q3 2026 11 182 — — 1
Q2 2026 170 — — —
Q1 2026 13 511 — — —
Q4 2025 171 — — —
Q3 2025 347 — — —
Q2 2025 626 — — —
Q1 2025 19 800 — — —
Turnover per employee in the quarter
11 182 €

Q3 2026 · calculated from EMTA data

Financials by year

2024 – 2025
Revenue, € 2025: 10 000 € · −39.4% vs 2024 · industry median 0 € · above 70% of the industry
05 00010 00015 00020 0002024 Company: 16 500 € Industry median: 0 €20242025 Company: 10 000 € Industry median: 0 €202505 00010 00015 00020 0002024 Company: 16 500 € Industry median: 0 €2025 Company: 10 000 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 10 865 € · −26.1% vs 2024 · industry median 0 € · above 82% of the industry
05 00010 00015 0002024 Company: 14 695 € Industry median: 0 €20242025 Company: 10 865 € Industry median: 0 €202505 00010 00015 0002024 Company: 14 695 € Industry median: 0 €2025 Company: 10 865 € Industry median: 0 €2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 108.7 % · +19.6 pp vs the year before · industry median 13.5 % · above 98% of the industry
02550751001252024 Company: 89.1 % Industry median: 15.8 %20242025 Company: 108.7 % Industry median: 13.5 %202502550751001252024 Company: 89.1 % Industry median: 15.8 %2025 Company: 108.7 % Industry median: 13.5 %2025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 26 116 € · −41.2% vs 2024
010 00020 00030 00040 00050 0002024 Company: 44 447 €20242025 Company: 26 116 €2025010 00020 00030 00040 00050 0002024 Company: 44 447 €2025 Company: 26 116 €2025
Equity, € 2025: 25 561 € · +73.9% vs 2024
010 00020 00030 0002024 Company: 14 696 €20242025 Company: 25 561 €2025010 00020 00030 0002024 Company: 14 696 €2025 Company: 25 561 €2025
Employees 2025: 0 · industry median 1 · above 2% of the industry
0.00.20.40.60.81.02024 Company: 0 Industry median: 120242025 Company: 0 Industry median: 120250.00.20.40.60.81.02024 Company: 0 Industry median: 12025 Company: 0 Industry median: 12025
  • Company
  • Industry median

Industry: Scientific research and development (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 10 000 10 865 0 26 116 25 561 0
2024 16 500 14 695 0 44 447 14 696 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
108.7 %
Net profit / revenue
Return on equity (ROE)
42.5 %
Net profit / equity
Return on assets (ROA)
41.6 %
Net profit / assets
Equity ratio
97.9 %
Equity / assets
Debt ratio
2.1 %
Liabilities / assets
Current ratio
47.06
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 29 Jun 2026 Company’s own e-Äriregister
2024 13 Dec 2023 – 31 Dec 2024 9 Apr 2025 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

  • Charalampos Paraskevas
    Member of a senior management body (management or supervisory board) · GRC · since 13 Dec 2023
  • Paraskevi Vourlioti
    Member of a senior management body (management or supervisory board) · GRC · since 13 Dec 2023
  • Stylianos Kotsopoulos
    Member of a senior management body (management or supervisory board) · GRC · since 13 Dec 2023

Founders and other persons

Activities (EMTAK)

  • 72101Research and experimental development on natural sciences and engineering Main

Rulings 3

All rulings (PDF)
Rulings
Number, date Title Deadline State Document
Ä 50242994
13 Dec 2023
 First entry In force
13 Dec 2023
 PDF
Ä 50242994 / M2
7 Dec 2023
 Ruling to eliminate deficiencies 6 Jan 2024 Deficiencies eliminated
11 Dec 2023
 PDF
Ä 50242994 / M1
4 Dec 2023
 Ruling to eliminate deficiencies 3 Jan 2024 Deficiencies eliminated
11 Dec 2023
 PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data